-treated BV-2 cells. At the molecular level, suppressor of ras val-2 (SRV2) promoted LPS-mediated mitochondrial damage by inducing mitochondrial fission. Sirt3 overexpression, which suppressed the transcription of SRV2 and thus suppressed mitochondrial fission, played an anti-apoptotic role in LPS-treated BV-2 cells. Furthermore, Sirt3 inhibited SRV2 expression via the Mst1-JNK pathway, and re-activation of this pathway abolished the protective effects of Sirt3 on mitochondrial damage and apoptosis. Taken together, our results indicate that Sirt3-induced, Mst1-JNK-SRV2 signaling pathway-dependent inhibition of mitochondrial fission protected against neuroinflammation-mediated cell damage in BV-2 microglia. Sirt3 might therefore be an effective treatment for neuroinflammation.
INTRODUCTION
Neuroinflammation is a pathological process that plays an important role in various acute and chronic brain disorders, including neurodegenerative disease, ischemic stroke, and traumatic brain injury [1] [2] [3] [4] . Neuroinflammation is characterized by activation of inflammatory cascades, excessive accumulation of inflammatory cells, and increases in cytokine levels. Glial cells, which play an important role in repairing damaged brain tissue, are the primary targets of neuroinflammation [5] . Extensive neuroinflammation causes microglial cell death which in turn further augments the inflammatory response [6, 7] . Reducing inflammation-mediated microglial cell death and promoting microglial cell survival are therefore vital for stopping the progression of neuroinflammation.
Mitochondria play a central role in cell death and survival [8] . Normal mitochondria produce ATP to support cellular metabolism [9] , whereas damaged mitochondria release pro-apoptotic factors to initiate programmed cell death [10] . Several studies have found that inflammation reduces mitochondrial membrane potential, promotes the opening of mitochondrial permeability transition pores (mPTPs), and increases oxidative stress [11] [12] [13] . However, the primary upstream mediator of these inflammationinduced pathological alterations in the mitochondria has not been identified. Recently, mitochondrial fission, in which individual mitochondria are divided into several compartments that can differ in membrane potential and ROS levels [14] , has been identified as an early feature of mitochondrial apoptosis [15] . These fragmented mitochondria are also a primary source of pro-apoptotic proteins such as cyt-c and Smac [16, 17] , which are released into the nucleus when mitochondrial apoptosis is activated. However, the effects of mitochondrial fission on neuroinflammation are largely unknown. AGING Several molecules capable of inducing mitochondrial fission, including Drp1, Mff, Mid49, and Fis1 have been identified [18] [19] [20] [21] . Once activated by stress conditions, these factors work together to form a contractile ring around the outer mitochondrial membrane. Suppressor of Ras Val-2 (SRV2), which alters the balance of skeleton protein F-actin, has also recently been identified as a promoter of mitochondrial fission [22] . In this study, we examined whether inflammation-induced activation of SRV2 contributes to mitochondrial fission. Sirtuin 3 (Sirt3), a member of the nicotinamide adenine dinucleotide-dependent histone deacetylase sub-family, has been identified as a key regulator of mitochondrial fission in several inflammation-related diseases, including high fat diet-induced hepatic inflammation [23] , wound repair [24] , atherosclerosis-related endothelial cell dysfunction [25] , and diabetic cardiomyopathy [26] . We also reported in recent studies that pharmacological activation of Sirt3 significantly reduces the susceptibility of microglial cells to inflammation stress [27] . However, the effects of Sirt3 on mitochondrial fission in cells under inflammation conditions have not yet been experimentally examined. In this study, we investigated whether Sirt3 could attenuate neuroinflammation by modulating SRV2-induced mitochondrial fission.
RESULTS

Overexpression of Sirt3 attenuates LPS-mediated BV-2 cell death
After exposure to LPS, which was used to induce neuroinflammation damage, cell viability as assessed in the MTT assay decreased dramatically ( Figure 1A ). Sirt3 expression also decreased rapidly at the transcriptional level ( Figure 1B ). These results indicated that Sirt3 downregulation and BV-2 cell damage may be linked. Adenovirus-mediated Sirt3 overexpression was used to verify the functional role of Sirt3 in neuroinflammation. As shown in Figure 1C , compared to the control group, LPS promoted release of LDH into the medium, which is indicative of cell death. Interestingly, Sirt3 adenovirus transfection largely reversed LPS-induced decreases in cell viability. In addition, ELISA indicated that caspase-3, the key promoter of cell death, was activated by LPS ( Figure  1D ). However, Sirt3 overexpression reduced caspase-3 activity in LPS-treated cells ( Figure 1D ), confirming the anti-apoptotic role of Sirt3 after neuroinflammation. Finally, the TUNEL assay was used to quantify the number of apoptotic cells. Compared to the control group, LPS increased the proportion of apoptotic cells to ~33%, while Sirt3 adenovirus transfection reduced this percentage ( Figure 1E, 1F ). Taken together, these results indicate that LPS-mediated BV-2 cell death could be reversed by Sirt3 overexpression.
LPS induces mitochondrial damage in BV-2 cells
At the molecular level, mitochondria have been identified as a potential target of neuroinflammation [28] . Accordingly, we explored the protective effects of Sirt3 on neuroinflammation-induced alterations in mitochondrial morphology. Under normal conditions, JC-1 probe fluorescence indicated that mitochondrial membrane potentials were generally high (Figure 2A , 2B). Interestingly, mitochondrial membrane potential was reduced after exposure to LPS (Figure 2A , 2B), as evidenced by increased green fluorescence of JC-1 probe. Transfection with Sirt3 adenovirus reversed the LPS-induced decrease in mitochondrial membrane potential (Figure 2A , 2B). ELISA was used to evaluate the activity of the mitochondrial respiratory complex, which plays a key role in the regulation of mitochondrial membrane potential. Compared to the control group, mitochondrial respiratory complex activity was reduced in response to LPS stress, and Sirt3 overexpression effectively restored mitochondrial respiratory complex function ( Figure 2C -2E). By restoring mitochondrial respiratory complex activity, Sirt3 overexpression also reversed the LPS-induced decrease in mitochondrial state-3 and state-4 respiration ( Figure 2F , 2G). Taken together, these results indicate that LPS impairs mitochondrial function by downregulating Sirt3.
Mitochondrial apoptosis is inhibited by Sirt3 overexpression in LPS-treated cells
Irreversible mitochondrial damage induces mitochondriarelated apoptosis, which is characterized by ROS overproduction, caspase-9 activation, opening of mPTPs, and the release of pro-apoptotic factors [29] . Immunofluorescence experiments indicated that levels of ROS were significantly increased in response to LPS stress ( Figure 3A , 3B). Interestingly, Sirt3 overexpression reduced ROS levels in BV-2 cells. In addition, ELISA assays also demonstrated that LPS treatment rapidly downregulated the activity of antioxidants such as SOD, GSH, and GPX ( Figure 3C -3E). Sirt3 overexpression reversed this LPS-induced decrease in antioxidant levels. In addition to ROS overproduction, LPS treatment increased mPTP opening rate, and Sirt3 overexpression largely reversed this effect ( Figure 3F ).
Translocation of pro-apoptotic proteins, such as Smac, released from the mitochondria to the nucleus is the most important step in the activation of mitochondrial apoptosis [30] . Immunofluorescence experiments AGING demonstrated that nuclear Smac levels increased rapidly in response to LPS ( Figure 3G , 3H). Interestingly, Sirt3 overexpression significantly reduced Smac levels in the nucleus. Due to the diffusion of Smac into the nucleus, caspase-9 activity was also apparently upregulated in LPS-treated cells ( Figure 3I ). However, Sirt3 overexpression attenuated LPS-mediated caspase-9 activation ( Figure 3I ). Taken together, these results indicate that Sirt3 overexpression can block the activation of LPS-mediated mitochondrial apoptosis in BV-2 cells.
Sirt3 overexpression reduces SRV2-associated mitochondrial fission
Mitochondrial fission has been identified as a novel mechanism by which mitochondrial apoptosis is initiated, and Sirt3 has been reported to inhibit mitochondrial apoptosis [31, 32] . In this study, we examined whether Sirt3 overexpression reduced mitochondrial apoptosis by repressing mitochondrial fission. First, mitochondrial fission was evaluated using immunofluorescence. As shown in Figure 4A , 4B, compared to the control group, mitochondria fragmentation was rapidly upregulated in response to LPS stress, indicating an activation of mitochondrial fission. Interestingly, Sirt3 overexpression reduced the amount of mitochondrial debris ( Figure 4A , 4B). Subsequently, parameters related to mitochondrial fission were measured via qPCR. As shown in Figure  4C -4H, compared to the control group, the levels of the pro-fission factors Drp1, Fis1, and Mff were significantly elevated after exposure to LPS stress. In addition, Sirt3 adenovirus transfection significantly reduced levels of these pro-fission factors ( Figure 4C-4H ). In contrast, anti-fission factor levels decreased when BV-2 cells were incubated with LPS. Sirt3 adenovirus transfection rapidly increased transcription of these anti-fission factors ( Figure  4C -4H). These results indicate that mitochondrial fission is activated by LPS and blocked by Sirt3.
Recently, SRV2 has been identified as a regulator of mitochondrial fission [33] . qPCR revealed that SRV2 expression was significantly elevated in LPS-treated cells and was reduced to near-normal levels after transfection with Sirt3 adenovirus ( Figure 4I ). To determine whether SRV2 is required for Sirt3-mediated mitochondrial fission, BV-2 cells were transfected with SRV2 adenovirus. As shown in Figure 4J , compared to the control group, LPS-induced mitochondrial fragmentation was reversed by Sirt3 overexpression. However, SRV2 adenovirus transfection abolished the inhibitory effects of Sirt3 on mitochondrial fission ( Figure 4J ). Taken together, these results confirm that SRV2 is essential for Sirt3-induced reduction of mitochondrial fission in LPStreated BV-2 cells.
Activation of mitochondrial fission abolishes the protective effects of Sirt3 overexpression in mitochondria
Next, we examined whether mitochondrial fission was critical for LPS-induced apoptosis in BV-2 cells. First, cell viability and apoptosis were assessed in Sirt3overexpressing BV-2 cells after administration of an activator of mitochondrial fission. As shown in Figure  5A , compared to the control group, LPS-induced reductions in cell viability were reversed by Sirt3 overexpression, while activation of mitochondrial fission reversed this effect. In addition, cell damage as assessed in an LDH release assay was increased by LPS and reduced by Sirt3 ( Figure 5B ). Interestingly, the protective effects of Sirt3 were blocked by the mitochondrial fission activator. TUNEL staining was used to quantify the number of apoptotic cells. As shown in Figure 5C , 5D, Sirt3 inhibited LPS-induced cell apoptosis, and mitochondrial fission activation reversed this effect. In addition, caspase-3, the key promoter of apoptotic signaling, was activated after exposure to LPS stress. Although Sirt3 adenovirus repressed LPS-mediated caspase-3 activation, this effect was abolished after re-activation of mitochondrial fission ( Figure 5E ). In sum, these data suggest that Sirt3 protects BV-2 cells against LPS-mediated apoptosis by repressing mitochondrial fission.
Sirt3 affects SRV2 via the Mst1-JNK pathway
The above data illustrated the mechanism by which Sirt3 preserves mitochondrial function and BV-2 cell viability in the presence of LPS. However, how Sirt3 affected SRV2 in LPS-treated BV-2 cells remained unclear. Our previous studies and other recent experiments have identified the Mst1-JNK axis as an important signaling pathway for neuroinflammation and inflammation-induced neuron death [34] . We therefore examined whether this pathway was activated by Sirt3 and contributed to SRV2 modification under LPS stress. Firstly, immunofluorescence was used to verify that Mst1 and JNK expression were altered in the presence of LPS. As shown in Figure 6A -6C, little Mst1 and JNK expression was observed in normal BV-2 cells. Interestingly, Mst1 and JNK levels increased rapidly after exposure to LPS and were reduced to near-normal levels after transfection with Sirt3 ( Figure 6A-6C) , indicating that the Mst1-JNK pathway was activated by LPS and inactivated by Sirt3 overexpression. To understand the role of the Mst1-JNK pathway in the pathogenesis of neuroinflammation, SRV2 transcription was measured in Sirt3-overexpressed cells treated with an Mst1-JNK pathway agonist. As shown in Figure 6D , compared to the control group, SRV2 transcription was upregulated by LPS stress. Although Sirt3 adenovirus repressed LPS-mediated SRV2 activation, reactivation of the Mst1-JNK pathway counteracted this effect. As shown in Figure 6E , 6F, immunofluorescence indicated that, compared to the control group, Sirt3 adenovirus transfection attenuated LPS-induced mitochondrial fragmentation; this inhibitory effect of Sirt3 was eliminated upon re-activation of Mst1-JNK pathway. Together, these results indicated that Sirt3 affects SRV2 expression via the Mst1-JNK pathway.
Re-activation of the Mst1-JNK pathway impairs Sirt3-mediated mitochondrial protection
A final set of experiments was conducted to verify whether Sirt3-mediated mitochondrial protection was controlled by the Mst1-JNK pathway. Total ATP production, for which mitochondria are solely responsible, was reduced by LPS and restored to nearnormal levels by Sirt3 overexpression. Interestingly, an Mst1-JNK pathway agonist caused a dramatic decline in ATP production in Sirt3-overexpression cells ( Figure  7A ). LPS-mediated inactivation of the mitochondrial respiratory complex was reversed by Sirt3 adenovirus, and this effect was blocked upon re-activation of the Mst1-JNK pathway (Figure 7B, 7C) .
Mitochondrial apoptosis was also measured in these experiments. LPS induced oxidative stress as indicated by high ROS levels in BV-2 cells ( Figure   7D , 7E). Although Sirt3 overexpression reduced generation of ROS, this anti-oxidative effect was abolished in cells treated with an Mst1-JNK pathway agonist ( Figure 7D, 7E) . Similarly, antioxidant activity was sustained by Sirt3 in the presence of LPS and decreased upon re-activation of Mst1-JNK pathway ( Figure 7F-7H ). Finally, caspase-9, a marker of mitochondrial apoptosis, was activated by LPS and reduced in Sirt3-overexpression cells ( Figure 7I) . Interestingly, the Mst1-JNk pathway agonist abolished the anti-apoptotic effects of Sirt3 on mitochondria. Taken together, our results demonstrate that Sirt3 protected mitochondria against LPS stress by inhibiting the Mst1-JNK axis. [35] . Mechanistically, microglia release cytokines to reduce inflammation response and migrate to damaged tissue to participate in regenerative processes. However, chronic neuroinflammation reduces the viability of and promotes apoptosis in microglia, which in turn promotes the progression of neuroinflammation. Thus, inhibition of microglia death might be an effective treatment for neuroinflammation. In this study, we identified Sirt3 as a key upstream promoter of cell survival in microglia exposed to inflammation. Sirt3 expression was downregulated under inflammatory conditions, and restoration of Sirt3 levels significantly reduced the apoptotic rate in microglia by promoting mitochondrial functions and repressing mitochondrial apoptosis. Mechanistically, LPS triggered mitochondrial fission by increasing SRV2 expression; excessive fission then triggered caspase-9-assocaited mitochondrial apoptosis. In contrast, Sirt3 overexpression repressed SRV2-related mitochondrial fission and promoted survival in microglia under inflammation conditions by blocking the Mst1-JNK pathway. To our knowledge, this is the first study to describe the protective role of Sirt3 in neuroinflammation and the molecular mechanism responsible for its effects. Treatments that increase Sirt3 expression to inhibit the Mst1-JNK-SRV2mitochondrial fission cascade might be highly effective in preventing neuroinflammation-induced microglia cell death.
Mitochondrial dysfunction has been associated with the progression of neuroinflammation [36] . For example, Aβ-mediated mitochondrial dysfunction contributes to the pathology of Alzheimer's disease [37, 38] . Damaged mitochondria fail to produce sufficient ATP to maintain brain function and metabolism [39] . Additionally, mitochondrial dysfunction is always accompanied by overproduction of ROS, an early feature of oxidative stress. Uncontrolled oxidative stress induces cell senescence and promotes inflammation response [40] . Preservation of mitochondrial function via mitophagy [41] or promitochondria drugs can be an effective treatment for neuroinflammation [42] . In this study, we also observed a reduction in mitochondrial function as a result of LPS stress. As was the case in previous studies, mitochondrial bioenergetics, redox balance, and survival were negatively affected by inflammation injury. Furthermore, our data illustrated that inflammation-related mitochondrial damage and mitochondrial apoptosis were largely the result of mitochondrial fission, which normally occurs in response to increases in metabolic rate. Abnormal mitochondrial fission, which results in the formation of non-functional mitochondrial debris, has been observed in response to stress-induced injury. This non-functional mitochondrial debris also acts as a source of pro-apoptotic proteins which eventually cause cell death. Our present results therefore suggest that inhibiting neuroinflammation-induced mitochondrial fission may help sustain mitochondrial homeostasis under LPS.
We also found that mitochondrial fission was inhibited by Sirt3, which agrees with previous studies. At the molecular level, Sirt3 inactivated the Mst1-JNK pathway and thus suppressed the expression of SRV2, a novel mediator of mitochondrial fission. The Mst1-JNK axis is known to control mitochondrial fission in liver cancer [43] , hyperglycemia-induced vascular dysfunction [44] , thyroid carcinoma [45] , breast cancer [46] , acute cardiac stress [47] , and colorectal cancer [48] . In addition, SRV2 induces mitochondrial fission by promoting F-actin polymerization [49, 50] . Our data demonstrate that SRV2 is regulated by the Mst1-JNK pathway in LPS-treated BV-2 cells. We have thus identified a novel downstream effector of the Mst1-JNK pathway as well as a new molecular mechanism underlying neuroinflammationinduced mitochondrial fission.
In order to confirm the clinical relevance of these cell line experiment results, they should be replicated in studies using animal models and human samples [51] . Additional studies are also necessary to determine whether Sirt3 regulates other mitochondrial fission factors such as Drp1 and Mff in the context of neuroinflammation [52, 53] . Taken together, our results indicate that neuroinflammation-associated pathology is due at least in part to Sirt3 downregulation, which in turn activates the Mst1-JNK pathway and subsequent SRV2-related mitochondrial fission [54] . Moreover, overexpression of Sirt3 blocked the Mst1-JNK pathway and thus suppressed SRV2-induced mitochondrial fission, reducing inflammation-mediated mitochondrial dysfunction and microglia cell apoptosis. This suggests that Sirt3 might be an effective treatment for neuroinflammation.
MATERIALS AND METHODS
Cell culture
BV-2 cells obtained from ATCC (Rockefeller, USA) were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, C11995500CP) supplemented with 10% (v/v) fetal bovine serum (FBS) (BI, 04-001-1ACS) and 1% penicillin/streptomycin (Genom, GNM15140). All cells were maintained in a humidified incubator with 95% air and 5% CO2 at 37°C. For the inflammation injury model, BV-2 cells were incubated with LPS as previously described [55] . Additionally, anisomycin (Ani, 10 μM, Selleck Chemicals, Houston, TX, USA), an Mst1-JNK pathway agonist, was added to the BV-2 cell medium for 2 hours in order to activate the JNK pathway.
Measurement of cell survival
Cell viability was determined using TUNEL, LDH release, and MTT assays. For the TUNEL assay, sections were deparaffinized and then incubated with proteinase K for 15 min at room temperature. Sections were then covered with TUNEL test solution containing fluorescein-conjugated dUTP and TdT enzyme at a ratio of 9:1 (v/v) in a humidified box at 37°C for 60 min. After washing, 4,6-diamidino-2-phenylindole (DAPI) was added to stain the cell nuclei. Images were taken using a fluorescent microscope (Olympus Corporation, Tokyo, Japan) [56, 57] . For LDH measurement, cellular medium samples were combined with 25 μL matrix buffer and 5 μL coenzyme I. After incubating for 15 min at 37°C, 25 μL 2,4-dinitrophenylhydrazine was added and incubated for another 15 min at 37°C. Finally, 250 μL 0.4mol/L NaOH was added to the mixture and incubated for 5 min, and optical density (OD) was measured using a microplate reader at 450 nm. For the MTT assay, 20 µL of MTT (5 mg/mL) in PBS solution was added to the medium after treatment and incubated for 4 h. The medium was then carefully removed and 150 µL of DMSO was added to each well to solubilize the crystals. Finally, OD was measured using a microplate reader at 490 nm [58] .
Measurement of MDA, GSH, and SOD levels
GPx, GSH, and SOD were quantified using commercial kits according to the manufacturer's protocol [59] . For GPx and SOD measurement, samples were rinsed with PBS and then homogenized and sonicated in lysis buffer on ice. After sonication, the lysed tissues were centrifuged at 10,000 g for 10 min to remove debris. For GSH measurement, samples were homogenized through three freeze-thaw cycles, and the tissue suspension was then centrifuged at 12,000 rpm for 5 min at 4°C. Supernatant GPx, GSH, and SOD levels were then measured. The protein concentration of each sample was determined using a BCA protein assay kit. In addition, GPx, GSH, and SOD levels were normalized to total protein concentrations [60] .
Cell fractionation and mitochondria isolation
BV-2 cells were plated in 10 cm dishes. Cytosolic and mitochondrial proteins were separated using a Cell Mitochondria Isolation Kit (Beyotime) according to the manufacturer's instructions [61] . Briefly, cells were washed with pre-cooled PBS and lysed with Cell Mitochondria Isolation buffer on ice. Mitochondria and cytoplasm were separated by grinding followed by centrifugation at 600 g for 10 minutes at 4 °C. The supernatant was then further centrifuged at 11,000 g for 10 minutes at 4°C. The pellet was collected as the mitochondria-enriched fraction and resuspended in mitochondrial lysis buffer. The remaining supernatant was centrifuged 12,000 g for 10 minutes at 4°C to collect cytosolic proteins. Protein concentrations were detected using a Multimode Plate Reader (PerkinElmer). Equal amounts of protein (20 μg) from each fraction were measured by western blotting [62] .
Immunofluorescence microscopy
Following treatment, BV-2 cells on coverslips were fixed in 4% paraformaldehyde. The cells were then permeabilized and blocked with 2% goat serum containing 0.5% Triton X-100 and 3% BSA for 1 h at room temperature. The cells were probed with the following primary antibodies: Smac (1:1000, Cell Signaling Technology, #15108), Mst1 (1:1000, Cell Signaling Technology, #3682), and p-JNK (1:1,000; Cell Signaling Technology, #9251). After three PBS washes, cells were stained with secondary antibody. All fluorescent images were acquired on a confocal microscope (Olympus).
Mitochondrial morphology assessment
Mitochondrial morphology was evaluated using MitoTracker Red (Invitrogen, USA) according to the manufacturer's instructions [63] . Briefly, the cells were incubated with 100 nM MitoTracker Red in RPMI 1640 medium for 30 min. Fluorescence was detected (490 nm excitation/525 nm emission) at 1000× magnification under a confocal laser scanning microscope (Olympus FV1200, Tokyo, Japan), and the images were analyzed using ImageJ (Bethesda, MD, USA). Mitochondrial fission evaluation was evaluated as described in previous studies [64, 65] .
Quantitative real-time PCR
mRNA was purified from cell pellets using the RNeasy Mini Kit (Qiagen #74104). mRNA was purified from EVs using the ExoRNeasy kit (Qiagen #77023). Up to 5 μg of total RNA were reverse-transcribed to obtain cDNA using SuperScript III (Invitrogen #18080-051). Quantitative PCR was performed using SYBR Green supermix (Bio-Rad #1725120). The manufacturers' protocols were followed for all of these procedures [66] . GAPDH was used as the housekeeping gene. The following primers were used in the present study: Sirt3 (Forward: 5′-GGTGCCTAGTGAGAGTGAGTCCCC-3′ and Reverse: 5′-TCGGGGCTGAAGAGGGAGAA GTC-3′); GAPDH (Forward: 5′-ACGGCAAATTCAA CGGCACAGTCA-3′ and Reverse: 5′-TGGGGGCATC GGCAGAAGG-3′); Mff (Forward: 5′-AAGTGGCTCT CACCCTAGCA-3′ and Reverse: 5′-TGCCCCACTCA CCAAATGT-3′); Fis1 (Forward: 5′-CAAGGAACTGG AGCGGCTCATTA-3′ and Reverse: 5′-GGACACAG CAAGTCCGATGAGT-3′); Mfn1 (Forward: 5′-TGTG GTGGACTTCCTCTTGGC-3′ and Reverse: 5′-GAGA ATGAATGGGCGTGGG-3′); Mfn2, (Forward: 5′-AGG ATGACAATGGCATTGGC-3′ and Reverse: 5′-CCGATCGTACATCCGCTTAAC-3′).
Measurement of mitochondrial ROS, mitochondrial membrane potential, and ATP production
Mitochondrial superoxide generation and membrane potential were measured as described previously [67] . ATP measurement kit (Beyotime, China) was used to measure ATP concentration as described previously [68] . Mitochondrial membrane potential was determined using the JC-1 probe (Beyotime, China). Red fluorescence from the JC-1 probe indicates normal mitochondrial membrane potential, whereas green fluorescence indicates abnormal mitochondrial membrane potential.
Adenovirus transfection
BV-2 cells were transfected with Sirt3 and SRV2 adenovirus (Shanghai Gene-Pharma Co., Shanghai, China) according to the HiPerFect Transfection Reagent Handbook (QIAGEN). Briefly, BV-2 cells were washed with PBS after treatment and then infected with Sirt3 and/or SRV2 adenovirus for 48h using Lipofectamine 2000 (Invitrogen, 11668027) according to the manufacturer's specifications [69] . Subsequently, cells were isolated and overexpression efficiency was confirmed via qPCR.
Protein extraction and western blot analysis
RIPA buffer was used to lyse the cells. Lysates were then centrifuged for 10 min at 12,000 rpm at 4°C. After quantification of protein concentration using BCA assay, equal amounts of protein were loaded on 10-12% gels for SDS-PAGE separation and then transferred onto PVDF membranes. After a 5% dry milk/TBST solution was used to block the membranes, primary antibodies, including rabbit IgG anti-LC3 (1:1000 dilution), and anti-GAPDH (1:5000 dilution) were added. After washing extensively with TBST, the goat anti-rabbit secondary antibody labeled with Alexa Fluor 680 (1:2000 dilution) was added. Membranes were scanned for far red signals using an Odyssey Imaging System (LI-COR, NE, USA). Quantity One Software (Bio-Rad, CA, USA) was used to quantify protein and expression levels by relative densitometry using beta-actin as the loading control.
Statistical analysis
Student's unpaired t-tests (two-group comparisons) and one-way ANOVAs (multigroup comparisons) were completed using GraphPad Prism. All data were analyzed to identify statistical significance between groups. P-values less than 0.05 were considered statistically significant, and the values are expressed as means ± SD.
